In low-grade glioma, the expression level of transforming growth factor beta 1 (TGF-β) and programmed cell death ligand 1 (PDL1) was positively correlated with immune risk score, and prognostic hub genes that were positively correlated with immune cell infiltration have also been revealed (25, 26). Here, TGFB1 is linked to glioma.